Innoviva (INVA) Deferred Taxes (2018 - 2026)
Innoviva (INVA) posted Deferred Taxes of $41.0 million for Q1 2026, up 907.81% on a QoQ basis from $4.1 million in Q3 2025, and up 17199.17% year-over-year from N/an in Q1 2025.
Innoviva (INVA) Deferred Taxes (2018 - 2026) Analysis & Trends
Innoviva's Deferred Taxes history runs 9 years deep, the most recent figure standing at $41.0 million for Q1 2026.
- Quarterly Deferred Taxes rose 17199.17% year-over-year to $41.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.2 million (up 259.76% YoY) and the FY2025 annual result came in at $43.8 million, up 447.52% from the prior year.
- Deferred Taxes was $41.0 million for Q1 2026 at Innoviva, up from $4.1 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $41.0 million in Q1 2026 and bottomed at -$15.4 million in Q3 2024.
- A 5-year average of $4.0 million and a median of -$240000.0 in 2025 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2024 — Deferred Taxes tumbled 1284.57% — and 2026, when it soared 17199.17%.
- Innoviva's Deferred Taxes stood at $29.3 million in 2022, then plunged by 103.81% to -$1.1 million in 2023, then tumbled by 1284.57% to -$15.4 million in 2024, then surged by 126.38% to $4.1 million in 2025, then soared by 907.81% to $41.0 million in 2026.
- Business Quant data shows INVA's Deferred Taxes at $41.0 million in Q1 2026, $4.1 million in Q3 2025, and -$637000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 41.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.04 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | -637,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Sep 30, 2024 | -15.44 Mn |
| Jun 30, 2024 | -15.25 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Sep 30, 2023 | -1.12 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | -812,000.00 |
| Sep 30, 2022 | 29.26 Mn |
| Jun 30, 2022 | -876,000.00 |
| Mar 31, 2022 | 6.86 Mn |
| Sep 30, 2021 | 65.60 Mn |
| Jun 30, 2021 | 25.33 Mn |
| Mar 31, 2021 | 19.74 Mn |
| Dec 31, 2020 | 15.73 Mn |
| Sep 30, 2020 | 8.87 Mn |
| Jun 30, 2020 | 19.89 Mn |
| Mar 31, 2020 | 15.93 Mn |